System and method for dialyzer evaluation

US11141515B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11141515-B2
Application numberUS-202016943794-A
CountryUS
Kind codeB2
Filing dateJul 30, 2020
Priority dateSep 29, 2017
Publication dateOct 12, 2021
Grant dateOct 12, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Embodiments of the disclosure provide a method for evaluating dialyzers used in different medical applications (e.g., hemodialysis). Red blood cell volume lost in a dialyzer is monitored by obtaining blood flowrate measurements and hematocrit measurements at input ports and output ports of the dialyzer. The flowrate and hematocrit measurements are used to determine an accumulation of red cell blood volume in the dialyzer. The measurements may be obtained in a lab environment with an in-vitro blood source or may be obtained in a clinical setting with an in-vivo blood source from a patient.

First claim

Opening claim text (preview).

The invention claimed is: 1. A system, comprising: a first sensor connected to a first portion of a blood flow path disposed on an input side of a dialyzer, wherein the first sensor is configured to obtain measurements relating to a characteristic of blood in the first portion of the blood flow path; a second sensor connected to a second portion of the blood flow path disposed on an output side of the dialyzer, wherein the second sensor is configured to obtain measurements relating to a characteristic of blood in the second portion of the blood flow path; and a controller configured to determine a red blood cell volume loss corresponding to an amount of red blood cells remaining in the dialyzer based on the measurements from the first and second sensors. 2. The system according to claim 1 , wherein the measurements relating to the characteristic of the blood in the first portion of the blood flow path are hemoglobin measurements, and the measurements relating to the characteristic of the blood in the second portion of the blood flow path are hemoglobin measurements. 3. The system according to claim 1 , wherein a flowrate of the blood in the first portion of the blood flow path is equal to a flowrate of the blood in the second portion of the blood flow path. 4. The system according to claim 1 , wherein the controller is further configured to determine a flowrate of the blood in the first portion of the blood flow path; wherein determining the red blood cell volume loss is further based on the determined flowrate of the blood in the first portion of the blood flow path. 5. The system according to claim 4 , wherein the flowrate of the blood in the first portion of the blood flow path is equal to a flowrate of the blood in the second portion of the blood flow path; wherein the controller is further configured to: determine an input red blood cell volume flow and an output red blood cell volume flow based on a measurement from the first sensor, a measurement from the second sensor, and the flowrate; and determine a difference ΔR between the input red blood cell volume flow and the output red blood cell volume flow; and wherein determining the red blood cell volume loss is further based on using one or more ΔR values over a period of time to determine an accumulated red blood cell volume loss value. 6. The system according to claim 4 , wherein determining the flowrate of the blood in the first portion of the blood flow path is based on a pumping rate of a pump configured to pump the blood in the first portion of the blood flow path into the dialyzer. 7. The system according to claim 4 , further comprising: a flowmeter coupled to the first portion of the blood flow path; wherein the controller is configured to determine the flowrate of the blood in the first portion of the blood flow path using the flowmeter. 8. The system according to claim 1 , wherein the controller is further configured to: determine a flowrate of the blood in the first portion of the blood flow path; determine a flowrate of the blood in the second portion of the blood flow path; determine an input red blood cell volume flow corresponding to blood flowing into the dialyzer based on a measurement from the first sensor and the flowrate of the blood in the first portion of the blood flow path; determine an output red blood cell volume flow corresponding to blood flowing out of the dialyzer based on a measurement from the second sensor and the flowrate of the blood in the second portion of the blood flow path; and determine a difference ΔR between the input red blood cell volume flow and the output red blood cell volume flow; and wherein determining the red blood cell volume loss is further based on using one or more ΔR values over a period of time to determine an accumulated red blood cell volume loss value. 9. The system according to claim 8 , wherein determining the flowrate of the blood in the second portion of the blood flow path is based on an ultrafiltration rate and the flowrate of the blood in the first portion of the blood flow path. 10. The system according to claim 1 , wherein the controller is further configured to output a rating for the dialyzer based on the red blood cell volume loss. 11. The system according to claim 1 , wherein the controller is further configured to output a comparison of the dialyzer to one or more other dialyzers based on respective red blood cell volume losses determined for each dialyzer. 12. The system according to claim 1 , wherein the first and second sensors are hematocrit measurement devices. 13. A system, comprising: a first port disposed in a first portion of a blood flow path disposed on an input side of a dialyzer, wherein the first port is configured to permit blood to be drawn from the first portion of the blood flow path; a second port disposed in a second portion of the blood flow path disposed on an output side of the dialyzer, wherein the second port is configured to permit blood to be drawn from the second portion of the blood flow path; and a controller configured to determine a red blood cell volume loss corresponding to an amount of red blood cells remaining in the dialyzer based on measurements relating to a characteristic of blood in the first portion of the blood flow path and measurements relating to a characteristic of blood in the second portion of the blood flow path, wherein the measurements relating to the characteristic of the blood in the first portion of the blood flow path correspond to blood drawn from the first portion of the blood flow path, and wherein the measurements relating to the characteristic of the blood in the second portion of the blood flow path correspond to blood drawn from the second portion of the blood flow path. 14. The system according to claim 13 , wherein the measurements relating to the characteristic of the blood in the first portion of the blood flow path are hemoglobin measurements, and the measurements relating to the characteristic of the blood in the second portion of the blood flow path are hemoglobin measurements. 15. The system according to claim 13 , wherein the measurements relating to the characteristic of the blood in the first portion of the blood flow path are hematocrit measurements, and the measurements relating to the characteristic of the blood in the second portion of the blood flow path are hematocrit measurements. 16. The system according to claim 13 , wherein a flowrate of the blood in the first portion of the blood flow path is equal to a flowrate of the blood in the second portion of the blood flow path. 17. The system according to claim 13 , wherein the controller is further configured to: determine a flowrate of the blood in the first portion of the blood flow path; and wherein determining the red blood cell volume loss is further based on the determined flowrate of the blood in the first portion of the blood flow path. 18. The system according to claim 17 , wherein the flowrate of the blood in the first portion of the blood flow path is equal to a flowrate of the blood in the second portion of the blood flow path; wherein the controller is further configured to: determine an input red blood cell volume flow and an output red blood cell volume flow based on a measurement corresponding to the blood in the first portion of the blood flow path, a measurement corresponding to the blood in the second portion of the blood flow path, and the flowrate; and determine a difference ΔR between the input red blood cell volume flow and the output red blood cell volume

Assignees

Inventors

Classifications

  • Testing of membrane fouling or clogging, e.g. amount or affinity · CPC title

  • automatically during use · CPC title

  • B01D61/22Primary

    Controlling or regulating · CPC title

  • hematocrit · CPC title

  • Measuring or controlling the flow rate · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11141515B2 cover?
Embodiments of the disclosure provide a method for evaluating dialyzers used in different medical applications (e.g., hemodialysis). Red blood cell volume lost in a dialyzer is monitored by obtaining blood flowrate measurements and hematocrit measurements at input ports and output ports of the dialyzer. The flowrate and hematocrit measurements are used to determine an accumulation of red cell b…
Who is the assignee on this patent?
Fresenius Medical Care Holdings Inc
What technology area does this patent fall under?
Primary CPC classification B01D61/22. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Oct 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).